1. Oh, Ah-Reum, Jeong, Yelin, Yu, Junjie, Pajvani, Utpal B, Kim, KyeongJin. 2022. Hepatocyte Kctd17 Inhibition Ameliorates Glucose Intolerance and Hepatic Steatosis Caused by Obesity-induced Chrebp Stabilization. In Gastroenterology, 164, 439-453. doi:10.1053/j.gastro.2022.11.019. https://pubmed.ncbi.nlm.nih.gov/36402191/
2. Jung, Young Hoon, Lee, Yun Ji, Dao, Tam, Hong, Soon-Sun, Kim, KyeongJin. 2024. KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression. In Clinical and molecular hepatology, 30, 895-913. doi:10.3350/cmh.2024.0364. https://pubmed.ncbi.nlm.nih.gov/39098817/
3. Mencacci, Niccolo E, Rubio-Agusti, Ignacio, Zdebik, Anselm, Bhatia, Kailash P, Wood, Nicholas W. 2015. A missense mutation in KCTD17 causes autosomal dominant myoclonus-dystonia. In American journal of human genetics, 96, 938-47. doi:10.1016/j.ajhg.2015.04.008. https://pubmed.ncbi.nlm.nih.gov/25983243/